Estee Lauder to present preclinical results on anti-aging products at WCD

Earlier today, Estee Lauder “announced that the company and its brands will present at the 25th World Congress of Dermatology (WCD) in Singapore from July 3-8, 2023. ELC researchers across 3 brands and ELC Research & Development will share novel clinical and preclinical results that demonstrate scientific innovation and leadership across emerging areas of skin health and anti-aging in the form of 5 poster presentations and a satellite symposium during this global event, which takes place every 4 years.” “We are thrilled to share key findings at the upcoming WCD from our most recent research efforts, which leverage insights from the fields of longevity and epigenetics to advance our understanding of the molecular pathways underlying inflammation and aging,” said Nadine Pernodet, PhD, Senior Vice President, Bioscience, ELC. “The breadth and depth of data to be presented further reflects our robust combined R&D and clinical testing capabilities. These highly integrated areas of focus support our exploration of new ingredients or methodologies to ultimately help shape and advance the skin care landscape.” Shares of Estee Lauder were up 4.1% in today’s trading, closing at $192.16.